ArticleGeroScience2026
An integrated multi-algorithm analysis to decipher senescence and metabolic characteristics in nucleus pulposus cells during disc degeneration.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Surviving the Nucleus Pulposus Desert: Next-Generation Strategies for Intervertebral Disc Cell Therapy.JOR spine · 2026Article
- The AI-driven blueprint: decoding intervertebral disc repair mechanisms for intelligent biomaterial design.Frontiers in cell and developmental biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Accumulating evidence has suggested that intervertebral disc degeneration (IVDD) serves as a health problem deserving attention from worldwide, owing to the low back pain and even disability it causes. Cellular senescence, an irreversible process of terminal cell cycle arrest, plays an essential role in the degeneration of nucleus pulposus (NP) cells and IVDD with an unknown underlying mechanism. Here, we have explored the senescence signature in IVDD through high dimensional weighted gene co-expression network analysis (hdWGCNA) algorithm in two single cell datasets (PRJCA014236 and GSE244889) to construct a novel signature called NP_Senescence, which accurately identifies the patients with IVDD. The efficacy and accuracy were validated in various external datasets, including two expression array datasets (GSE70362 and GSE34095) and one single cell dataset (GSE230809). Additionally, the accuracy of the specific model was also verified with the senescent cell identification (SenCID) algorithm. IVDD patients with a high NP_Senescence score exhibited the characteristics of compensated activation of hyaluronic acid monomers synthesis and abnormal status of DNA damage repair through single-cell Flux Estimation Analysis (scFEA) algorithm. Furthermore, the NP_Senescence was negatively associated with the level of AMP and Glucose-1-phosphate, while positively associated with the level of β-alanine and UDP-glucuronic acid. In conclusion, we constructed a novel disc-specific scoring model NP_Senescence by comprehensively analyzing the senescence-related genes of IVDD, which can be used for patient early diagnosis and treatment, as well as the identification of metabolic characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.